Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 828 across all filing types
Latest filing 2024-05-15 Declaration of Voting R…
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated May 15th, 2024, announcing the 'Total number of outstanding shares and voting rights of ADOCIA as of April 30th, 2024.' It explicitly cites compliance with French regulations (Code de Commerce and AMF charter) for disclosing share capital structure information. This type of periodic disclosure regarding the total number of shares and voting rights, often required monthly or quarterly by regulators like the AMF, does not fit neatly into the primary financial report categories (10-K, IR) or specific corporate actions (DIV, SHA, POS). While it relates to capital structure, it is a mandatory regulatory disclosure of share count, not a financing event (CAP) or a general share issue announcement (SHA). Since it is a specific regulatory disclosure that doesn't match the other defined categories, the most appropriate classification is the general regulatory filing fallback category, RNS (Regulatory Filings). The document length is moderate (4775 chars), but its content is purely a notification of required data points, not the full report itself.
2024-05-15 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release ("COMMUNIQUE DE PRESSE") from ADOCIA dated May 15, 2024, titled "Information relative au nombre d'actions et de droits de vote en date du 30 avril 2024". It explicitly states it is published in accordance with French commercial code and AMF regulations (Article L.233-8 II and Article 223-16) to report the total number of shares and voting rights as of a specific past date (April 30, 2024). This type of mandatory periodic disclosure regarding share capital structure and voting rights is a specific regulatory filing requirement in France, often related to major shareholding notifications or general capital structure updates. Given the options, this content most closely aligns with a notification regarding changes in significant share ownership or capital structure, which falls under Major Shareholding Notification (MRQ) or potentially Share Issue/Capital Change (SHA) if the change was recent. However, the core purpose is reporting the current voting rights count, which is a key component of major shareholding disclosures or general capital structure reporting. Since it is a formal, periodic regulatory disclosure about the capital base, and not a general announcement of a report (RPA) or a broad regulatory filing (RNS), and it deals directly with share counts, MRQ (Major Shareholding Notification) is the most appropriate fit, as these reports often include the total voting rights calculation. It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER).
2024-05-15 French
Inside Information / Other news releases
Earnings Release Classification · 1% confidence The document is titled "ADOCIA Reports First Quarter 2024 Financial Results and Provides a Business Update." It contains detailed financial highlights for the first quarter (Q1 2024), including revenue tables, cash position details as of March 31, 2024, and operational updates on drug development programs. This structure—reporting on a specific, shorter fiscal period (quarterly) with financial tables and management commentary—is characteristic of an Interim/Quarterly Report (IR). It is more comprehensive than a simple Earnings Release (ER) which usually only provides key highlights, and it is not the full Annual Report (10-K). Q1 2024
2024-05-14 English
Informations privilégiées / Autres communiqués
Earnings Release Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and its content focuses on summarizing the company's financial results for the first quarter of 2024 ("résultats financiers du premier trimestre 2024"), key operational updates (M1Pram, BioChaperone programs), and cash position. This structure—a brief announcement highlighting key figures and operational milestones for a specific short period (Q1)—is characteristic of an Earnings Release (ER). It is not the full, detailed annual report (10-K) or a comprehensive interim report (IR), but rather the initial announcement of the period's results. Q1 2024
2024-05-14 French
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is a short announcement titled "ADOCIA annonce la mise à disposition de son Document d'Enregistrement Universel pour l'année 2023" (ADOCIA announces the availability of its Universal Registration Document for 2023). It explicitly states that the 'document d'enregistrement universel 2023' has been filed with the AMF (Autorité des Marchés Financiers) and is now available on the company's and AMF's websites. The document length is very short (2752 characters). According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication or availability of a larger report (like the Universal Registration Document, which contains the Annual Financial Report), it should be classified as a Report Publication Announcement (RPA).
2024-04-29 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is titled "ADOCIA Announces the Release of its Universal Registration Document for the Year 2023" and explicitly states that the company has filed its 2023 Universal Registration Document with the French regulator (AMF). The text then details what is included in that document (annual financial report, governance report, auditor reports, etc.) and provides links where the document is available. Since the document itself is an announcement about the publication of a major regulatory filing (the Universal Registration Document, which often encompasses elements of a 10-K or comprehensive annual filing in European contexts), and the text is short (2602 chars) and focuses on the release/availability rather than containing the full content of the reports, it fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K, AR, or IR itself, but the announcement of its availability.
2024-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.